cover image - Medical Pharmacology and Therapeutics Elsevier eBook on Vitalsource, 5th Edition
ISBN: 9780702071935
Copyright: 2018
Publication Date: 08-02-2017
Page Count: 744
Imprint: Elsevier
List Price: $67.99

Medical Pharmacology and Therapeutics Elsevier eBook on Vitalsource, 5th Edition

by Derek G. Waller, BSc, DM, MBBS, FRCP and Anthony Sampson, MA, PhD, FHEA, FBPhS

Elsevier eBook on VitalSource

cover image - Medical Pharmacology and Therapeutics Elsevier eBook on Vitalsource, 5th Edition
ISBN: 9780702071935
Copyright: 2018
Publication Date: 08-02-2017
Page Count: 744
Imprint: Elsevier
List Price: $67.99
Was $67.99

Now $59.83

Or $0.00 with a valid access code

Medical Pharmacology and Therapeutics, now in its fifth edition, offers medical students all they need to know to become safe and effective prescribers. It forms a complete, integrated resource for basic pharmaceutical science, pathophysiology, clinical pharmacology, and therapeutics.

    • Clear, disease-based approach
    • Presentation of how drugs are used in clinical practice
    • Succinct explanations of the major pathogenic mechanisms of each disease and consequent clinical signs and symptoms
    • Comprehensive reviews of major drug classes relevant to each disease
    • Structured approach to the principles of disease management – outlining core principles of drug choice and planning a therapeutic regimen for common diseases
    • Quick-reference drug compendia illustrating key similarities and differences among all BNF-listed drugs in each class
  • SECTION 1 General principles
    1. Principles of pharmacology and mechanisms of drug action
    2. Pharmacokinetics
    3. Drug discovery, safety and efficacy
    4. The nervous system, neurotransmission and the peripheral autonomicnervous system

    SECTION 2 The cardiovascular system
    5. Ischaemic heart disease
    6. Systemic and pulmonary hypertension
    7. Heart failure
    8. Cardiac arrhythmias
    9. Cerebrovascular disease and dementia
    10. Peripheral vascular disease
    11. Haemostasis

    SECTION 3 The respiratory system
    12. Asthma and chronic obstructive pulmonary disease
    13. Respiratory disorders: cough, respiratory stimulants, cysticfibrosis and neonatal respiratory distress syndrome

    SECTION 4 The renal system
    14. Diuretics
    15. Disorders of micturition
    16. Erectile dysfunction

    SECTION 5 The nervous system
    17. General anaesthetics
    18. Local anaesthetics
    19. Opioid analgesics and the management of pain
    20. Anxiolytics, sedatives and hypnotics
    21. The major psychotic disorders: schizophrenia and mania
    22. Depression, attention deficit hyperactivity disorder and narcolepsy
    23. Epilepsy
    24. Extrapyramidal movement disorders and spasticity
    25. Other neurological disorders: multiple sclerosis, motor neuron diseaseand Guillain–Barré syndrome
    26. Migraine

    SECTION 6 The musculoskeletal system
    27. The neuromuscular junction and neuromuscular blockade
    28. Myasthenia gravis
    29. Non-steroidal anti-inflammatory drugs
    30. Rheumatoid arthritis, other inflammatory arthritides and osteoarthritis
    31. Hyperuricaemia and gout

    SECTION 7 The gastrointestinal system
    32. Nausea and vomiting
    33. Dyspepsia and peptic ulcer disease
    34. Inflammatory bowel disease
    35. Constipation, diarrhoea and irritable bowel syndrome
    36. Liver disease
    37. Obesity

    SECTION 8 The immune system
    38. The immune response and immunosuppressant drugs
    39. Antihistamines and allergic disease

    SECTION 9 The endocrine system and metabolism
    40. Diabetes mellitus
    41. The thyroid and control of metabolic rate
    42. Calcium metabolism and metabolic bone disease
    43. Pituitary and hypothalamic hormones
    44. Corticosteroids (glucocorticoids and mineralocorticoids)
    45. Female reproduction
    46. Androgens and anabolic steroids
    47. Anaemia and haematopoietic colony-stimulating factors
    48. Lipid disorders

    SECTION 10 The skin and eyes
    49. Skin disorders
    50. The eye

    SECTION 11 Chemotherapy
    51. Chemotherapy of infections
    52. Chemotherapy of malignancy

    SECTION 12 General features: toxicity and prescribing
    53. Drug toxicity and overdose
    54. Substance abuse and dependence
    55. Prescribing, adherence and information about medicines
    56. Drug therapy in special situations
  • Derek G. Waller, BSc, DM, MBBS, FRCP, Former Consultant Physician and Senior Clinical Lecturer, Department of Medicine, University Hospital Southampton, Southampton, UK and Anthony Sampson, MA, PhD, FHEA, FBPhS, Professorial Fellow in Clinical Pharmacology & Director of Undergraduate Programmes, Faculty of Medicine, University of Southampton
    Southampton, United Kingdom
    • Ways of Reading
      • The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
      • This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
      • No information about nonvisual reading is available
    • Conformance
      • No information is available
    • Navigation
      • Table of contents to all chapters of the text via links
      • Page list to go to pages from the print source version
    • Rich Content
      • No information is available
    • Hazards
      • No information is available
    • Product Content
      • No information is available
    • Legal Considerations
      • No information is available
    • Additional Accessibility Information
      • Page breaks included from the original print source
      • For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
      • E-publication includes basic navigation (usually less detailed than TOC-based navigation)
      • Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
      • All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
      • The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.
Was $67.99

Now $59.83

Or $0.00 with a valid access code